Transcriptome (FFPE)

Home/Sequencing/Transcriptome (FFPE)

Project Description

Transcriptome analyses and differential gene expression.

Feasible via samples obtained from FFPE and urine.

  • Analysis of human transcriptome differential expressions transcripts included in RefSeq databases can be obtained from a maximum of 10ng RNA (compatible with samples obtained from FFPE).
  • New chemistry of sequencing to help solve false positive problems.
  • Bio-data analysis: analysis of edgeR and DESeq2 genetic differential expression.
  • Results: a final clinical report of the results will be sent through a secure download link.
  • Estimated processing time: results delivered within 15 to 30 days, depending on the scaling of the samples.

Ion Torrent™ Transcriptome Certified Service Provider

Whole Transcriptome Sequencing (WTS).

The analysis methodology is based on the creation of complementary DNA (cDNA) in order to generate a transcriptome library for research purposes. To apply NGS technologies to transcriptome analysis it has been established that this is more complex and dynamic of what initially had been described, including a wide variety of RNA molecules (short RNA, RNA …).

All the transcriptome sequencing is the more complete, cost-effective method for identification and quantification of RNA from different types of source material. Currently the Ion PI ™ chip – depending on desired sequencing coverage – allows analysis of one to four full transcriptomas chip (assuming more than 10 million sequences mapped sample), thanks to the obtaining of between 60-80 million sequences that allow the detection of low abundance transcripts and rare types of RNA, among other applications.

Another approach is the use of targets in the study of RNA, enabling the analysis of hundreds of samples (up to 384) in a single process of sequencing. Genetracer Biotech has taken advantage of the workflow of the AmpliseqTM Ion to be applied in the study of targets on RNA. This technology allows to choose among more than 20,000 specific genes using a tool online. There are currently also available specific panels for cancer and the apoptotic pathways. The technology of the AmpliseqTM together with the design of primers allows to analyze up to 300 genes selected by the researcher in a single reaction based on minimum quantities of RNA, from 500 pg.

Altogether, the analysis of the differential expression of RNA genome-wide or specific targets for specific objectives offers researchers a better understanding of biological pathways and molecular mechanisms that regulate cell fate, the development and progression of the disease.

Genetracer is prepared to allow first-time customers a success-based free-pilot of its WTS / DGE analysis in Transcriptome  service. Please contact us for more details

Example of the mouse transcriptome sequencing

86,645,077 Total reads




Project Details